Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
Open Access
- 24 March 2017
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 5 (1) , 1-13
Abstract
Intrathecal immunoglobulin G (IgG) synthesis, cerebrospinal fluid (CSF) oligoclonal IgG bands and lesional IgG deposition are seminal features of multiple sclerosis (MS) disease pathology. Both the specific targets and pathogenic effects of MS antibodies remain poorly characterized. We produced IgG1 monoclonal recombinant antibodies (rAbs) from clonally-expanded plasmablasts recovered from MS patient CSF. Among these were a subset of myelin-specific MS rAbs. We examined their immunoreactivity to mouse organotypic cerebellar slices by live binding and evaluated tissue injury in the presence and absence of human complement. Demyelination, glial and neuronal viability, and complement pathway activation were assayed by immunofluorescence microscopy and compared to the effects of an aquaporin-4 water channel (AQP4)-specific rAb derived from a neuromyelitis optica (NMO) patient. MS myelin-specific rAbs bound to discrete surface domains on oligodendrocyte processes and myelinating axons. Myelin-specific MS rAbs initiated complement-dependent cytotoxicity to oligodendrocytes and induced rapid demyelination. Demyelination was accompanied by increased microglia activation; however, the morphology and survival of astrocytes, oligodendrocyte progenitors and neurons remained unaffected. In contrast, NMO AQP4-specific rAb initiated complement-dependent astrocyte damage, followed by sequential loss of oligodendrocytes, demyelination, microglia activation and neuronal death. Myelin-specific MS antibodies cause oligodendrocyte loss and demyelination in organotypic cerebellar slices, which are distinct from AQP4-targeted pathology, and display seminal features of active MS lesions. Myelin-specific antibodies may play an active role in MS lesion formation through complement-dependent mechanisms.Keywords
Funding Information
- National Multiple Sclerosis Society (Collaborative Research Grant)
- National Eye Institute (EY022936)
- National Institute of Neurological Disorders and Stroke (NS072141, NS25304)
- the Guthy-Jackson Charitable Foundation
This publication has 33 references indexed in Scilit:
- Astrocytes in multiple sclerosisMultiple Sclerosis Journal, 2016
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explantsActa Neuropathologica, 2015
- Treatment of neuromyelitis optica: state-of-the-art and emerging therapiesNature Reviews Neurology, 2014
- The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis OpticaBrain Pathology, 2013
- Oligodendrocytes and the early multiple sclerosis lesionAnnals of Neurology, 2012
- Pathology of Demyelinating DiseasesAnnual Review of Pathology: Mechanisms of Disease, 2012
- Regulation of Oligodendrocyte Differentiation and MyelinationScience, 2010
- Proteolipid Promoter Activity Distinguishes Two Populations of NG2-Positive Cells throughout Neonatal Cortical DevelopmentThe Journal of Neuroscience, 2002
- Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelinationAnnals of Neurology, 2000
- Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MSNeuropathology and Applied Neurobiology, 2000